NCT06380127

Feasibility and Effectiveness of Concurrent Exercise Training on Frail Older Adults Living in Nursing Homes

Feasibility and Effectiveness of a 12-week Concurrent Exercise Training on Physical Performance, Muscular Strength and Circulating Myokines in Frail Older Adults Living in Nursing Homes: a Cluster Randomized Crossover Trial
Universidade do Porto·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Frailty
Drug/Device/Intervention
Exercise training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Universidade do Porto
Location
Porto, Portugal
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2021
End date
Dec 15, 2023
Enrollment
46 participants
Primary outcome

Change from Baseline on Short Physical Performance Battery (SPBB)

Summary

The present study is a crossover randomized controlled trial that aims to investigate the
 effects of concurrent exercise training over usual care on physical performance, muscle
 strength, and myokines concentrations in frail older adults living in nursing homes.The main
 questions it aims to answer is: Can a 12-week exercise intervention provide beneficial
 effects on physical performance, muscle strength and myokines among the most frail
 participants? Researchers will compare this intervention to usual care. Nursing homes
 (comprising participants) will be randomly assigned to a sequence of interventions (AB or
 BA), being A -exercise and B usual care. Participants will be assessed before and after each
 intervention.

ICD-10 classifications
Unattended deathIndividuals with autosomal fragile site
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380127
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06380127 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade do Porto and is currently Completed. The study focuses on Frailty. Target enrollment is 46 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.